STRIDE: Semaglutide Shows it Has Legs in Peripheral Artery Disease
Med Page Today
MARCH 29, 2025
(MedPage Today) -- CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building its positions in peripheral artery disease (PAD) and with an oral formulation, based on two major.
Let's personalize your content